CHF

VT5 announces decision of Takeover Board – VT5 informiert über Verfügung der Übernahmekommission – VT5 annonce la décision de la Commission des offres publiques d’acquisition

Retrieved on: 
Tuesday, November 7, 2023
Knowledge, Sale, Arnold S de Beer, Internet, UEV, TAG Tegernsee Immobilien und Beteiligung, Takeover, CHF, Existence, Une, Ordinance, OPA, Commitment, UN, Holding company, Security (finance), Adhesive, Rope, Furniture, Nightclub, Ziff

The present decision will be published on the website of the Takeover Board subsequent to its publication pursuant to section 4 above.

Key Points: 
  • The present decision will be published on the website of the Takeover Board subsequent to its publication pursuant to section 4 above.
  • 3 of the Ordinance of the Takeover Board on Public Takeover Offers) may file an objection with the Takeover Board against this decision.
  • 3 OOPA) peut former opposition auprès de la Commission des offres publiques d’acquisition contre cette décision.
  • Le délai commence à courir dès le premier jour de bourse suivant la publication de la décision de la Commission des OPA sur leur site web.

AC Immune Reports Third Quarter 2023 Financial Results and Provides a Corporate Update

Retrieved on: 
Friday, November 3, 2023
Amyloid, Financial statement, Luxembourg Centre for Systems Biomedicine, PD, Tax, Target, G&A, AC, Conference, Quarter, PET, University of Luxembourg, AAIC, ALS, KOL, Tau, University, The Michael J. Fox Foundation, Safety, ABATE, Diagnosis, D, CHF, Pharmaceutical industry, Medical imaging

Dr. Andrea Pfeifer, CEO of AC Immune SA, commented: “As we look to year-end and into 2024, AC Immune is poised to achieve multiple milestones across our clinical programs.

Key Points: 
  • Dr. Andrea Pfeifer, CEO of AC Immune SA, commented: “As we look to year-end and into 2024, AC Immune is poised to achieve multiple milestones across our clinical programs.
  • We remain on track to report safety and immunogenicity data from the AD cohort of our ABATE trial of ACI-24.060 this year.
  • Then, in the first half of 2024 results are anticipated from the important Abeta-PET imaging analyses on amyloid plaque reduction following 6 months of treatment.
  • The Company’s cash balance provides sufficient capital resources to progress into Q4 2024 without considering receipt of potential future milestone payments.

Hospital Inpatient Care Dominates Palliative Care Market as Specialized Services Gain Traction - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 1, 2023
Health, Hospitals, Age, Nursing home, Heart, Central nervous system disease, Vomiting, Prevalence, Conditional sentence, Clifton Springs Hospital & Clinic, Diabetes, CNS, Incidence, Nausea, Vels Institute of Science, Technology & Advanced Studies, Quality of life, Growth, Caregiver, COVID-19, Asthma, Hospital, Telehealth, Arthritis, Anxiety, Alzheimer's disease, Pain, Patient, Hospice, COPD, CHF, Health care, Nursing, Residential care, Dementia, Palliative care, Cancer

By Type: The global palliative care market encompasses five key segments: Hospital Inpatient Care, Hospice Inpatient Care, Nursing Home, Residential Facility Center, and Others.

Key Points: 
  • By Type: The global palliative care market encompasses five key segments: Hospital Inpatient Care, Hospice Inpatient Care, Nursing Home, Residential Facility Center, and Others.
  • Hospital inpatient care holds the largest market share and is anticipated to experience significant growth, driven by the increasing availability of specialized palliative care services within hospitals.
  • By End-User: Palliative care services are provided through various end-users, including Hospitals & Clinics, Home Care Settings, Palliative Care Centers, and Others.
  • Lack of Access to Palliative Care Services in Underdeveloped Countries: Inadequate access to palliative care services in underdeveloped regions presents a significant challenge to market expansion.

Eighth Place for the Class40 IBSA in the Furious Stage Le Havre-Lorient

Retrieved on: 
Tuesday, October 31, 2023
Sports, General Sports, Entertainment, Philanthropy, Events, Concerts, Sailing, General Health, Pharmaceutical, Health, Other Philanthropy, Transat Jacques Vabre, Bénéteau Figaro 3, BOAT, Figaro, Route, Courage, Dermatology, LE, Endocrinology, Fastnet, Gruppo TIM, Inflammation, IBSA, Multimedia, Leg, La, Atlantic Ocean, Class40, Risk, Partnership, Solitaire, ULDB, Running, Transat, 2022 Route du Rhum, Quality, Reproductive medicine, Future, ARC, Channel, Movement, Pain, Philosophy, Panerai, CHF, Maserati, Whaling, Shipbuilding

“This first stage”, commented Giorgio Pisani, Vice President IBSA Group and Project leader of Sailing into the Future.

Key Points: 
  • “This first stage”, commented Giorgio Pisani, Vice President IBSA Group and Project leader of Sailing into the Future.
  • The first international regatta in which Alberto Bona participated with the Class40 IBSA was the Route du Rhum 2022.
  • In 2022 he started the new project, with the support of the IBSA Group: with the new Class40 IBSA, he participated in the Route du Rhum 2022, finishing in eighth position.
  • IBSA: IBSA (Institut Biochimique SA) is a Swiss multinational pharmaceutical Company, founded in 1945 in Lugano.

Sandoz successfully issues CHF 750 million in inaugural bonds

Retrieved on: 
Thursday, October 26, 2023
EBITDA, Person, BNP Paribas, BBB, Media release, S&P, UBS, Failure, CHF, Security (finance), Bank, Novartis, BAA2

Two tranches of CHF 400 million and CHF 350 million with maturities of 3 and 8 years, carrying 2.125% and 2.600% fixed coupons, respectively

Key Points: 
  • Two tranches of CHF 400 million and CHF 350 million with maturities of 3 and 8 years, carrying 2.125% and 2.600% fixed coupons, respectively
    Basel, October 26, 2023 – Sandoz, the global leader in generic and biosimilar medicines, today announced the issuance of two highly successful inaugural CHF bonds with gross proceeds of CHF 750 million.
  • This debut transaction was driven by overwhelming investor demand and marks a solid entry for Sandoz as a borrower in debt capital markets.
  • The bonds carry 2.125% and 2.600% fixed coupons with tenors of 3 and 8 years, maturing on 17.11.2026 and 17.11.2031, respectively.
  • Sandoz continues to target a net debt to core EBITDA ratio of 1.7 to 2.0 times and to maintain its solid investment grade rating.

Medical Properties Trust, Inc. Confirms Long-Term Strength, Stability and Performance of Business Model in Third Quarter Results

Retrieved on: 
Thursday, October 26, 2023
REIT, Hospitals, Health, Commercial Building & Real Estate, Construction & Property, Centene Corporation, PHP, SMN, United Kingdom, NYSE, Health care, International, Government, Regulation, MPT, Telephone, Disclosure, GAAP, Acquisition, Sold, Tenant, Priory, Circle Health, Genolier Swiss Medical Network SA, Growth, Medical Properties Trust, NFFO, Webcast, Regulation Fair Disclosure, Hospital, MPW, Running, Collection, Investment, Hyundai Doosan Infracore, Bed, Calendar, EBITDAR, CHF, Life insurance, Commercial property, Lease, Bank, Cryptocurrency

“Our business model remains strong and stable,” said Edward K. Aldag, Jr., Chairman, President and Chief Executive Officer.

Key Points: 
  • “Our business model remains strong and stable,” said Edward K. Aldag, Jr., Chairman, President and Chief Executive Officer.
  • As of September 30, 2023, MPT’s portfolio included 441 properties and approximately 44,000 licensed beds.
  • During the third quarter, Centene Corporation agreed to sell Circle Health (“Circle”) ($2 billion) to PureHealth at a value of roughly $1.2 billion.
  • Call participants are to ask the operator to be joined to the Medical Properties Trust, Inc. conference call upon dialing in.

EQS-News: beaconsmind AG: beaconsmind Group accelerates transformation under new leadership and concludes further strategic acquisitions

Retrieved on: 
Thursday, October 26, 2023
Software as a service, ARR, LAN, Gross income, Tax, ISIN, EBITDA, Acquisition, WLAN, Pocs, Software, WAN, Bank statement, Advertising, Growth, LBM, EUR, Depreciation, Management, Infrastructure, CHF, Security (finance), Bookkeeping, Retail, Network equipment provider, Medical imaging

Accretive effect on Group financials will be fully captured in the FY2024 annual figures with an expected closing still in November 2023.

Key Points: 
  • Accretive effect on Group financials will be fully captured in the FY2024 annual figures with an expected closing still in November 2023.
  • With the acquisitions of the two companies beaconsmind Group has concluded the strategic transformation into two synergetic segments: Infrastructure and Software/SaaS and will provide reporting of financials on these two segments going forward.
  • The new management team has established a new beaconsmind Group offering selecting a best-in-class infrastructure and software offering on a modular basis.
  • Beaconsmind Group will only target strategic add-on acquisitions at very attractive acquisition prices of around 1x revenues and 5-7x pre-synergies EBITDA.

EQS-News: Adaptivv Financial Technologies AG: Adaptivv and Tareno Ltd. enter into partnership

Retrieved on: 
Thursday, October 26, 2023
ETH Zurich, Risk management, Partnership, FINMA, CHF, Cryptocurrency

Established as a company in 2000, Tareno is in the meantime one of the 15 largest independent asset managers in Switzerland with 2.5 bn CHF assets under management.

Key Points: 
  • Established as a company in 2000, Tareno is in the meantime one of the 15 largest independent asset managers in Switzerland with 2.5 bn CHF assets under management.
  • Adaptivv Financial Technologies Ltd. is a spin-off from ETH Zurich, founded in 2016 and is a recognized specialist for advanced risk management technology in finance.
  • Within this cooperation framework, Adaptivv provides for Tareno customized risk management and quantitative research across all asset classes.
  • Based upon the Adaptivv Sensor® technology, weekly stability signals for each financial instrument are calculated and can be used to control exposure for every portfolio constituent.

EQS-News: beaconsmind AG: beaconsmind Group announces 1H 2023 financials

Retrieved on: 
Thursday, October 26, 2023
Software as a service, ARR, Gross income, Tax, ISIN, EBITDA, Bank statement, LBM, Depreciation, Management, CHF, Bookkeeping

Strong balance sheet with CHF 6.8MM equity and confirmed cash breakeven; 1H 2023 still with low legacy revenues and EBITDA

Key Points: 
  • Strong balance sheet with CHF 6.8MM equity and confirmed cash breakeven; 1H 2023 still with low legacy revenues and EBITDA
    Zurich, Switzerland – 24 October 2023 – beaconsmind Group (ISIN: CH0451123589 – Ticker: MLBMD), a leading SaaS provider in the field of location-based marketing (LBM) & analytics, has issued the first half year 2023 figures.
  • For the first time financials of FREDERIX Hotspot GmbH (“FREDERIX”) and Socialwave GmbH were partially reflected due to the closing in February and May 2023, respectively.
  • beaconsmind Group has prepared consolidated financial statements in accordance with IFRS and reports its key financial figures in Swiss francs.
  • For the first half year of 2023, beaconsmind Group posted revenues of CHF 2.7MM vs. previous 2H 2022 of CHF 0.6MM and Earnings before interest, taxes, depreciation, and amortisation (EBITDA) of CHF -0.5MM  vs. previous 2H 2022 of CHF -3.18MM.

HAUTE: Valuation at CHF 100 million in just 17 months of listing

Retrieved on: 
Thursday, October 26, 2023
CHF, Marketing

In merely 17 months of being listed on the stock exchange, Haute Capital Partners has brilliantly distinguished itself by reaching a valuation of CHF 100 million, a memorable milestone reflecting its rapid ascent in the financial market.

Key Points: 
  • In merely 17 months of being listed on the stock exchange, Haute Capital Partners has brilliantly distinguished itself by reaching a valuation of CHF 100 million, a memorable milestone reflecting its rapid ascent in the financial market.
  • Faced with robust and steadily increasing demand, Haute Capital Partners has not only managed to satisfy its investors, but also exceeded all expectations by surpassing the symbolic bar of 100 million in valuation.
  • This milestone is not just a figure: it embodies the efficiency, dynamism, and confidence that now surround the brand.
  • We are proud of what we have accomplished, and even more motivated for the future,” said Thibault Bürki, CEO of Haute Capital Partners.